These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15370616)

  • 1. Temozolomide treatment in glioma--experiences in two university hospitals in Finland.
    Mäenpää HO; Aaltonen K; Mäntylä R; Minn H
    Acta Oncol; 2004; 43(6):579-84. PubMed ID: 15370616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of the cost effectiveness of temozolomide for malignant gliomas in British Columbia.
    Mabasa VH; Taylor SC
    J Oncol Pharm Pract; 2006 Jun; 12(2):105-11. PubMed ID: 16984749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Australian experience with temozolomide for the treatment of recurrent high grade gliomas.
    Harris MT; Rosenthal MA; Ashley DL; Cher L
    J Clin Neurosci; 2001 Jul; 8(4):325-7. PubMed ID: 11437571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
    Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
    Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review.
    Dinnes J; Cave C; Huang S; Major K; Milne R
    Health Technol Assess; 2001; 5(13):1-73. PubMed ID: 11359682
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death.
    Wasserfallen JB; Ostermann S; Leyvraz S; Stupp R
    Neuro Oncol; 2005 Apr; 7(2):189-95. PubMed ID: 15831237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of temozolomide in patients with progressive low-grade glioma.
    Quinn JA; Reardon DA; Friedman AH; Rich JN; Sampson JH; Provenzale JM; McLendon RE; Gururangan S; Bigner DD; Herndon JE; Avgeropoulos N; Finlay J; Tourt-Uhlig S; Affronti ML; Evans B; Stafford-Fox V; Zaknoen S; Friedman HS
    J Clin Oncol; 2003 Feb; 21(4):646-51. PubMed ID: 12586801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebral hemorrhage secondary to thrombocytopenia in a patient treated with temozolomide.
    Sure D; Dunn I; Norden A; Anderson WS
    Clin Neurol Neurosurg; 2010 Oct; 112(8):741-2. PubMed ID: 20434832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Favourable result for temozolomide in recurrent high-grade glioma].
    Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide in children with progressive low-grade glioma.
    Gururangan S; Fisher MJ; Allen JC; Herndon JE; Quinn JA; Reardon DA; Vredenburgh JJ; Desjardins A; Phillips PC; Watral MA; Krauser JM; Friedman AH; Friedman HS
    Neuro Oncol; 2007 Apr; 9(2):161-8. PubMed ID: 17347491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economics of temozolomide in brain cancer.
    Crott R
    Expert Opin Pharmacother; 2007 Aug; 8(12):1923-9. PubMed ID: 17696793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.
    Bower M; Newlands ES; Bleehen NM; Brada M; Begent RJ; Calvert H; Colquhoun I; Lewis P; Brampton MH
    Cancer Chemother Pharmacol; 1997; 40(6):484-8. PubMed ID: 9332462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide chemotherapy in patients with recurrent malignant gliomas.
    Yang SH; Kim MK; Lee TK; Lee KS; Jeun SS; Park CK; Kang JK; Kim MC; Hong YK
    J Korean Med Sci; 2006 Aug; 21(4):739-44. PubMed ID: 16891823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temozolomide as first-line agent in treating high-grade gliomas: phase II study.
    Chibbaro S; Benvenuti L; Caprio A; Carnesecchi S; Pulerà F; Faggionato F; Serino D; Galli C; Andreuccetti M; Buxton N; Gagliardi R
    J Neurooncol; 2004; 67(1-2):77-81. PubMed ID: 15072451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status.
    Janinis J; Efstathiou E; Panopoulos C; Samantas E; Aravantinos G; Christodoulou C; Skarlos D
    Med Oncol; 2000 May; 17(2):106-10. PubMed ID: 10871815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
    Agarwala SS; Kirkwood JM; Gore M; Dreno B; Thatcher N; Czarnetski B; Atkins M; Buzaid A; Skarlos D; Rankin EM
    J Clin Oncol; 2004 Jun; 22(11):2101-7. PubMed ID: 15169796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-schedule dose-dense temozolomide in refractory gliomas.
    Berrocal A; Perez Segura P; Gil M; Balaña C; Garcia Lopez J; Yaya R; Rodríguez J; Reynes G; Gallego O; Iglesias L;
    J Neurooncol; 2010 Feb; 96(3):417-22. PubMed ID: 19669096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide in the treatment of recurrent malignant glioma.
    Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD
    Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide.
    Koekkoek JA; Dirven L; Heimans JJ; Postma TJ; Vos MJ; Reijneveld JC; Taphoorn MJ
    J Neurooncol; 2016 Jan; 126(2):347-54. PubMed ID: 26547911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.